
Agentic AI in Healthcare Is Moving Closer to Real-World Clinical Use
ARPA-H and medical researchers are testing AI agents that can use clinical tools, navigate health records and defer uncertain decisions to clinicians.
26 articles · page 2 of 3 · showing 13 to 24

ARPA-H and medical researchers are testing AI agents that can use clinical tools, navigate health records and defer uncertain decisions to clinicians.

Agentic AI is moving into healthcare as ARPA-H, researchers and health systems test clinical agents that can use tools, manage workflows and escalate care.

AI medical scribes, ambient AI healthcare, Microsoft Dragon Copilot, Abridge, Nabla, clinical documentation AI, healthcare AI

Philips has introduced Alturion, a new ultrasound system that uses AI-assisted measurements and workflow automation to support busy hospital imaging teams.

Evvy raised $40 million in Series B funding to expand vaginal microbiome testing, women’s health research, fertility work and personalised care.

OpenAI integrates ChatGPT Health with Epic’s electronic health record system, allowing clinicians to review patient data and use AI tools in healthcare workflows.

OpenAI researcher Miles Wang is reportedly leaving the company to launch an AI drug discovery startup, with funding talks valuing the venture at about $2 billion.

Anthropic introduces Claude Science, a research workbench that helps scientists manage workflows, analyse data, and accelerate discoveries using existing Claude AI models.

Reid Hoffman is leaving Microsoft’s board after nearly a decade to dedicate more time to Manus, his AI-driven drug discovery startup. The LinkedIn co-founder plans to focus on innovation…

Triomics has raised $22 million in Series B funding to scale its oncology-focused AI platform that helps cancer centres streamline clinical workflows, patient data management, and trial…

Amazon has introduced a healthcare AI assistant on its website and mobile app to help users find medical information, understand symptoms, and discover healthcare products.

OpenEvidence has reached a $12 billion valuation after raising a new funding round led by Thrive Capital and DST, underscoring strong investor demand for AI-driven healthcare tools.